PAHC logo

PAHC EBITDA

annual EBITDA:

$166.89M+$68.30M(+69.27%)
June 30, 2025

Summary

  • As of today (September 12, 2025), PAHC annual EBITDA is $166.89 million, with the most recent change of +$68.30 million (+69.27%) on June 30, 2025.
  • During the last 3 years, PAHC annual EBITDA has risen by +$54.69 million (+48.74%).
  • PAHC annual EBITDA is now at all-time high.

Performance

PAHC EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPAHCincome statement metrics

quarterly EBITDA:

$45.91M-$13.45M(-22.66%)
June 30, 2025

Summary

  • As of today (September 12, 2025), PAHC quarterly EBITDA is $45.91 million, with the most recent change of -$13.45 million (-22.66%) on June 30, 2025.
  • Over the past year, PAHC quarterly EBITDA has increased by +$24.07 million (+110.22%).
  • PAHC quarterly EBITDA is now -22.66% below its all-time high of $59.36 million, reached on March 31, 2025.

Performance

PAHC quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPAHCincome statement metrics

TTM EBITDA:

$186.47M+$24.07M(+14.82%)
June 30, 2025

Summary

  • As of today (September 12, 2025), PAHC TTM EBITDA is $186.47 million, with the most recent change of +$24.07 million (+14.82%) on June 30, 2025.
  • Over the past year, PAHC TTM EBITDA has increased by +$87.88 million (+89.13%).
  • PAHC TTM EBITDA is now at all-time high.

Performance

PAHC TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherPAHCincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

PAHC EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+69.3%+110.2%+89.1%
3 y3 years+48.7%+43.6%+66.2%
5 y5 years+58.0%+58.2%+76.3%

PAHC EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+69.3%-22.7%+149.7%at high+89.1%
5 y5-yearat high+69.3%-22.7%+149.7%at high+89.1%
alltimeall timeat high+188.1%-22.7%+156.4%at high+941.5%

PAHC EBITDA History

DateAnnualQuarterlyTTM
Jun 2025
$166.89M(+69.3%)
$45.91M(-22.7%)
$186.47M(+14.8%)
Mar 2025
-
$59.36M(+20.3%)
$162.40M(+22.6%)
Dec 2024
-
$49.32M(+54.7%)
$132.43M(+18.1%)
Sep 2024
-
$31.88M(+46.0%)
$112.09M(+13.7%)
Jun 2024
$98.60M(-13.5%)
$21.84M(-25.7%)
$98.60M(-9.7%)
Mar 2024
-
$29.39M(+1.4%)
$109.17M(+1.5%)
Dec 2023
-
$28.98M(+57.6%)
$107.52M(-2.1%)
Sep 2023
-
$18.39M(-43.3%)
$109.81M(-3.7%)
Jun 2023
$113.99M(+1.6%)
$32.42M(+16.9%)
$113.99M(+0.4%)
Mar 2023
-
$27.73M(-11.3%)
$113.55M(-0.4%)
Dec 2022
-
$31.27M(+38.5%)
$113.96M(+1.9%)
Sep 2022
-
$22.57M(-29.4%)
$111.89M(-0.3%)
Jun 2022
$112.21M(+4.0%)
$31.97M(+13.6%)
$112.21M(+4.1%)
Mar 2022
-
$28.15M(-3.6%)
$107.81M(-0.3%)
Dec 2021
-
$29.19M(+27.5%)
$108.09M(+1.0%)
Sep 2021
-
$22.89M(-17.0%)
$107.02M(-0.8%)
Jun 2021
$107.85M(+2.1%)
$27.57M(-3.0%)
$107.84M(-1.3%)
Mar 2021
-
$28.43M(+1.1%)
$109.29M(-1.0%)
Dec 2020
-
$28.12M(+18.5%)
$110.43M(+0.1%)
Sep 2020
-
$23.72M(-18.3%)
$110.33M(+4.3%)
Jun 2020
$105.64M(-7.9%)
$29.02M(-1.9%)
$105.79M(+3.2%)
Mar 2020
-
$29.57M(+5.5%)
$102.53M(+0.1%)
Dec 2019
-
$28.02M(+46.1%)
$102.41M(-4.2%)
Sep 2019
-
$19.18M(-25.6%)
$106.93M(-8.0%)
Jun 2019
$114.71M
$25.76M(-12.5%)
$116.22M(-4.2%)
Mar 2019
-
$29.45M(-9.5%)
$121.32M(-2.4%)
Dec 2018
-
$32.55M(+14.4%)
$124.33M(+0.0%)
DateAnnualQuarterlyTTM
Sep 2018
-
$28.46M(-7.8%)
$124.30M(-1.1%)
Jun 2018
$124.80M(+5.4%)
$30.86M(-4.9%)
$125.70M(+1.5%)
Mar 2018
-
$32.47M(-0.1%)
$123.79M(+2.0%)
Dec 2017
-
$32.51M(+8.8%)
$121.40M(+2.6%)
Sep 2017
-
$29.87M(+3.2%)
$118.35M(+0.4%)
Jun 2017
$118.41M(+5.4%)
$28.95M(-3.7%)
$117.92M(+1.8%)
Mar 2017
-
$30.07M(+2.1%)
$115.84M(+2.1%)
Dec 2016
-
$29.46M(+0.1%)
$113.42M(+1.3%)
Sep 2016
-
$29.43M(+9.5%)
$111.96M(+2.0%)
Jun 2016
$112.38M(+2.8%)
$26.87M(-2.8%)
$109.82M(+0.3%)
Mar 2016
-
$27.64M(-1.3%)
$109.50M(+0.4%)
Dec 2015
-
$28.01M(+2.7%)
$109.02M(+2.9%)
Sep 2015
-
$27.29M(+2.8%)
$105.98M(-2.9%)
Jun 2015
$109.27M(+28.2%)
$26.55M(-2.3%)
$109.15M(+7.5%)
Mar 2015
-
$27.17M(+8.8%)
$101.49M(+4.9%)
Dec 2014
-
$24.97M(-18.0%)
$96.76M(+2.8%)
Sep 2014
-
$30.46M(+61.2%)
$94.11M(+10.4%)
Jun 2014
$85.25M(+11.6%)
$18.89M(-15.8%)
$85.25M(-0.9%)
Mar 2014
-
$22.44M(+0.6%)
$86.00M(+3.6%)
Dec 2013
-
$22.31M(+3.3%)
$82.98M(+4.4%)
Sep 2013
-
$21.60M(+9.9%)
$79.45M(+4.9%)
Jun 2013
$76.39M(+14.3%)
$19.65M(+1.2%)
$75.75M(+35.0%)
Mar 2013
-
$19.42M(+3.4%)
$56.10M(+52.9%)
Dec 2012
-
$18.78M(+4.9%)
$36.68M(+104.9%)
Sep 2012
-
$17.91M
$17.91M
Jun 2012
$66.85M(+15.4%)
-
-
Jun 2011
$57.93M
-
-

FAQ

  • What is Phibro Animal Health Corporation annual EBITDA?
  • What is the all time high annual EBITDA for Phibro Animal Health Corporation?
  • What is Phibro Animal Health Corporation annual EBITDA year-on-year change?
  • What is Phibro Animal Health Corporation quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Phibro Animal Health Corporation?
  • What is Phibro Animal Health Corporation quarterly EBITDA year-on-year change?
  • What is Phibro Animal Health Corporation TTM EBITDA?
  • What is the all time high TTM EBITDA for Phibro Animal Health Corporation?
  • What is Phibro Animal Health Corporation TTM EBITDA year-on-year change?

What is Phibro Animal Health Corporation annual EBITDA?

The current annual EBITDA of PAHC is $166.89M

What is the all time high annual EBITDA for Phibro Animal Health Corporation?

Phibro Animal Health Corporation all-time high annual EBITDA is $166.89M

What is Phibro Animal Health Corporation annual EBITDA year-on-year change?

Over the past year, PAHC annual EBITDA has changed by +$68.30M (+69.27%)

What is Phibro Animal Health Corporation quarterly EBITDA?

The current quarterly EBITDA of PAHC is $45.91M

What is the all time high quarterly EBITDA for Phibro Animal Health Corporation?

Phibro Animal Health Corporation all-time high quarterly EBITDA is $59.36M

What is Phibro Animal Health Corporation quarterly EBITDA year-on-year change?

Over the past year, PAHC quarterly EBITDA has changed by +$24.07M (+110.22%)

What is Phibro Animal Health Corporation TTM EBITDA?

The current TTM EBITDA of PAHC is $186.47M

What is the all time high TTM EBITDA for Phibro Animal Health Corporation?

Phibro Animal Health Corporation all-time high TTM EBITDA is $186.47M

What is Phibro Animal Health Corporation TTM EBITDA year-on-year change?

Over the past year, PAHC TTM EBITDA has changed by +$87.88M (+89.13%)
On this page